Corpus Intelligence IC Memo — SANTIAM MEMORIAL HOSPITAL 2026-04-26 11:21 UTC
IC Memo — SANTIAM MEMORIAL HOSPITAL
Investment Committee Memorandum | OR | 40 beds | Grade C | EBITDA uplift $6.2M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

SANTIAM MEMORIAL HOSPITAL

CCN 380056 | MARION, OR | 40 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

SANTIAM MEMORIAL HOSPITAL is a 40-bed under-performing / distressed in MARION, OR with $84.5M in net patient revenue and a -13.9% operating margin. The hospital serves a payer mix of 19.6% Medicare, 7.5% Medicaid, and 72.8% commercial.

Thesis: Turnaround. Our ML models identify $6.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -13.9% to -6.5% (+736bps).

Net Revenue HCRIS$84.5M
Current EBITDA COMPUTED$-11.7M
Operating Margin COMPUTED-13.9%
Occupancy HCRIS23.0%
Revenue / Bed COMPUTED$2.1M
Net-to-Gross HCRIS45.3%
Distress Probability ML55.1%

2. Market Context & Competitive Position

63
OR Hospitals
-8.1%
State Median Margin
28
Comparable Hospitals

OR has 63 Medicare-certified hospitals with a median operating margin of -8.1%. The target's margin of -13.9% places it below the state median. Among 28 size-comparable peers (20-80 beds), the median margin is -5.8%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (20-80), prioritizing same-state peers. 28 hospitals in the comp set.

HospitalStateBedsRevenueMargin
SANTIAM MEMORIAL HOSPITAL (Target)OR40$84.5M-13.9%
SAMARITAN ALBANY GENERAL HOSPIOR67$220.1M-12.0%
GOOD SHEPHERD MEDICAL CENTEROR25$177.5M5.3%
COLUMBIA MEMORIAL HOSPITALOR25$165.9M5.2%
SAMARITAN LEBANON COMM HOSPITAOR25$157.9M3.9%
PROVIDENCE NEWBERG MEDICAL CENOR40$151.5M10.0%
SAMARITAN PACIFIC COMM HOSPITAOR25$141.7M3.7%
GRANDE RONDE HOSPITALOR25$134.8M-4.1%
PROVIDENCE MILWAUKIE HOSPITALOR40$128.8M-9.6%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $6.2M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.8M+210bp18mo
Cost to Collect4.5%2.5%$1.7M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.7M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.0M+122bp9mo
Clean Claim Rate88.0%96.0%$54K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.8M
Cost to Collect
$1.7M
Denial Rate Reduction
$1.7M
A/R Days Reduction
$1.0M
Clean Claim Rate
$54K
Total EBITDA Uplift$6.2M
Current EBITDA$-11.7M
+ RCM Uplift+$6.2M
Pro Forma EBITDA$-5.5M
Current Margin-13.9%
Pro Forma Margin-6.5%
WC Released (1x)$3.2M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-18.0M$-15.1M0.00x-100.0%
Base (11x exit)10.0x11.0x$-18.0M$-22.4M0.00x-100.0%
Bull Case9.0x11.0x$-16.2M$-7.8M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-16.2M$-13.3M0.00x-100.0%
Bear Case11.0x10.0x$-19.8M$-40.3M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-19.8M$-50.8M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 23.0%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 55.1% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 28 hospitals with 20-80 beds
  • Same-state prioritization (n=29)
  • Comp margins: P25=-16.5% / P50=-5.8% / P75=3.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.